Prescription Drugs and the DEA: Interactions and Issues with Controlled Substances Registrants

$120.00

Kara Morris

Series: Drug Transit and Distribution, Interception and Control
BISAC: LAW093000

The Drug Enforcement Administration (DEA) administers and enforces the Controlled Substances Act (CSA) as it pertains to ensuring the availability of controlled substances, including certain prescription drugs, for legitimate use while limiting their availability for abuse and diversion. The CSA requires those handling controlled substances to register with DEA.

This book examines to what extent registrants interact with DEA about their CSA responsibilities, and registrants’ perspectives on those interactions; how state agencies and national associations interact with DEA, and their perspectives on those interactions; and stakeholders’ perspectives on how DEA enforcement actions have affected prescription drug abuse and diversion and access to those drugs for legitimate needs. The book also highlights certain non-criminal regulatory requirements.
(Imprint: Nova)

Table of Contents

Table of Contents

Preface

Prescription Drugs: More DEA Information about Registrants’ Controlled Substances Roles Could Improve Their Understanding and Help Ensure Access
(United States Government Accountability Office)

The Controlled Substances Act: Regulatory Requirements
(Brian T. Yeh)

Index

Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!